Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients.
Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients.
复制标题
糖尿病与COVID-19患者住院死亡风险增加相关:一项包括18,506例患者的系统性综述和荟萃分析
DOI:
10.1007/s42000-020-00246-2
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Kokkinidis DG
中科院分区:
文献类型:
--
作者:
Palaiodimos L;Chamorro-Pareja N;Karamanis D;Li W;Zavras PD;Chang KM;Mathias P;Kokkinidis DG
Infectious diseases are more frequent and can be associated with worse outcomes in patients with diabetes. The aim of this study was to systematically review and conduct a meta-analysis of the available observational studies reporting the effect of diabetes on mortality among hospitalized patients with COVID-19. The Medline, Embase, Google Scholar, and medRxiv databases were reviewed for identification of eligible studies. A random effects model meta-analysis was used, and I2 was utilized to assess the heterogeneity. In-hospital mortality was defined as the endpoint. Sensitivity, subgroup, and meta-regression analyses were performed. A total of 18,506 patients were included in this meta-analysis (3713 diabetics and 14,793 non-diabetics). Patients with diabetes were associated with a higher risk of death compared with patients without diabetes (OR 1.65; 95% CI 1.35–1.96; I2 77.4%). The heterogeneity was high. A study-level meta-regression analysis was performed for all the important covariates, and no significant interactions were found between the covariates and the outcome of mortality. This meta-analysis shows that that the likelihood of death seems to be higher in diabetic patients hospitalized with COVID-19 compared with non-diabetic patients. Further studies are needed to assess whether this association is independent or not, as well as to investigate the role of adequate glycemic control prior to infection with COVID-19. The online version of this article (10.1007/s42000-020-00246-2) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
5
作者:
Bode, Bruce;Garrett, Valerie;Klonoff, David C.
通讯作者:
Klonoff, David C.
影响因子:
16.2
作者:
Allard R;Leclerc P;Tremblay C;Tannenbaum TN
通讯作者:
Tannenbaum TN
DOI:
10.1136/bmj.b2535
发表时间:
2009-07-21
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者:
PRISMA Group
影响因子:
1.9
作者:
Javanian, Mostafa;Bayani, Masomeh;Ebrahimpour, Soheil
通讯作者:
Ebrahimpour, Soheil
影响因子:
--
作者:
Geerlings, SE;Hoepelman, AIM
通讯作者:
Hoepelman, AIM